GBA1 and Parkinson disease: We conclude from these results that treatment of multiple gene-edited WT/WT DA neurons with exogenous GluSph phenocopied the mTOR hyperactivation and α-synuclein abnormalities observed in the GBA1/PD–DA mutant neurons, and that these effects of GluSph were prevented by mTOR inhibition.